Clinical trials
Phase 3 Hematologic Diseases trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Active, not recruiting | 6 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Loxo Oncology, Inc. | 5 |
| Pfizer | 3 |
| BioMarin Pharmaceutical | 2 |
| Genzyme, a Sanofi Company | 2 |
| Amgen | 1 |
| Ariad Pharmaceuticals | 1 |
| Seagen Inc. | 1 |
| Sierra Oncology LLC - a GSK company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 16 |
| Lymphoma, Non-Hodgkin | 6 |
| Hemophilia A | 5 |
| Lymphoma, B-Cell | 5 |
| Blood Coagulation Disorders | 4 |
| Blood Coagulation Disorders, Inherited | 4 |
| Bone Marrow Diseases | 4 |
| Coagulation Protein Disorders | 4 |
| Genetic Diseases, Inborn | 4 |
| Hemorrhagic Disorders | 4 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.